Global Artesunate Market Overview:
Global Artesunate Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Artesunate Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Artesunate involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artesunate Market:
The Artesunate Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Artesunate Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artesunate Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Artesunate market has been segmented into:
Malaria Treatment
Schistosomiasis Treatment
Other Parasitic Diseases
By Application, Artesunate market has been segmented into:
Injectable
Oral Tablets
Inhalation
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artesunate market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artesunate market.
Top Key Players Covered in Artesunate market are:
Sanofi
Zhejiang Hisun Pharmaceutical
Guilin Pharmaceutical
Yangtze River Pharmaceutical Group
Farmanguinhos
Kinetics Eco Solutions
Bristol Myers Squibb
Hikma Pharmaceuticals
Nanjing Rar Pharmaceutical
Alok Enterprises
Unifab
Hetero Drugs
Viatris
Karnavati Medical
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Artesunate Market Type
4.1 Artesunate Market Snapshot and Growth Engine
4.2 Artesunate Market Overview
4.3 Malaria Treatment
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Malaria Treatment: Geographic Segmentation Analysis
4.4 Schistosomiasis Treatment
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Schistosomiasis Treatment: Geographic Segmentation Analysis
4.5 Other Parasitic Diseases
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Other Parasitic Diseases: Geographic Segmentation Analysis
Chapter 5: Artesunate Market Application
5.1 Artesunate Market Snapshot and Growth Engine
5.2 Artesunate Market Overview
5.3 Injectable
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Injectable: Geographic Segmentation Analysis
5.4 Oral Tablets
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Oral Tablets: Geographic Segmentation Analysis
5.5 Inhalation
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Inhalation: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Artesunate Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 SANOFI
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 ZHEJIANG HISUN PHARMACEUTICAL
6.4 GUILIN PHARMACEUTICAL
6.5 YANGTZE RIVER PHARMACEUTICAL GROUP
6.6 FARMANGUINHOS
6.7 KINETICS ECO SOLUTIONS
6.8 BRISTOL MYERS SQUIBB
6.9 HIKMA PHARMACEUTICALS
6.10 NANJING RAR PHARMACEUTICAL
6.11 ALOK ENTERPRISES
6.12 UNIFAB
6.13 HETERO DRUGS
6.14 VIATRIS
6.15 KARNAVATI MEDICAL
Chapter 7: Global Artesunate Market By Region
7.1 Overview
7.2. North America Artesunate Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Malaria Treatment
7.2.2.2 Schistosomiasis Treatment
7.2.2.3 Other Parasitic Diseases
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Injectable
7.2.3.2 Oral Tablets
7.2.3.3 Inhalation
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Artesunate Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Malaria Treatment
7.3.2.2 Schistosomiasis Treatment
7.3.2.3 Other Parasitic Diseases
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Injectable
7.3.3.2 Oral Tablets
7.3.3.3 Inhalation
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Artesunate Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Malaria Treatment
7.4.2.2 Schistosomiasis Treatment
7.4.2.3 Other Parasitic Diseases
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Injectable
7.4.3.2 Oral Tablets
7.4.3.3 Inhalation
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Artesunate Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Malaria Treatment
7.5.2.2 Schistosomiasis Treatment
7.5.2.3 Other Parasitic Diseases
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Injectable
7.5.3.2 Oral Tablets
7.5.3.3 Inhalation
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Artesunate Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Malaria Treatment
7.6.2.2 Schistosomiasis Treatment
7.6.2.3 Other Parasitic Diseases
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Injectable
7.6.3.2 Oral Tablets
7.6.3.3 Inhalation
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Artesunate Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Malaria Treatment
7.7.2.2 Schistosomiasis Treatment
7.7.2.3 Other Parasitic Diseases
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Injectable
7.7.3.2 Oral Tablets
7.7.3.3 Inhalation
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Artesunate Scope:
|
Report Data
|
Artesunate Market
|
|
Artesunate Market Size in 2025
|
USD XX million
|
|
Artesunate CAGR 2025 - 2032
|
XX%
|
|
Artesunate Base Year
|
2024
|
|
Artesunate Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Sanofi, Zhejiang Hisun Pharmaceutical, Guilin Pharmaceutical, Yangtze River Pharmaceutical Group, Farmanguinhos, Kinetics Eco Solutions, Bristol Myers Squibb, Hikma Pharmaceuticals, Nanjing Rar Pharmaceutical, Alok Enterprises, Unifab, Hetero Drugs, Viatris, Karnavati Medical.
|
|
Key Segments
|
By Type
Malaria Treatment
Schistosomiasis Treatment
Other Parasitic Diseases
By Applications
Injectable
Oral Tablets
Inhalation
|
